Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis b
Symptom |hepatocellular carcinoma
Sentences 143
PubMedID- 22212935 Prevention of hepatocellular carcinoma in patients with chronic hepatitis b virus infection.
PubMedID- 25983748 The role of tlr3 in hepatocellular carcinoma (hcc) with hepatitis b virus (hbv) infections is not well understood.
PubMedID- 24583062 Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis b treated with entecavir vs lamivudine.
PubMedID- 23781497 Evaluated the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection and found that the c > t polymorphisms at foki position in the vdr gene served as a potential biomarker for the risk and the disease severity of hcc in those infected with hbv.
PubMedID- 26159441 Background: this study was designed to evaluate the prognostic value of three systemic inflammation markers, neutrophil to lymphocyte ratio (nlr), platelet to lymphocyte ratio (plr), and prognostic nutritional index (pni), for hepatocellular carcinoma (hcc) associated with hepatitis b (hbv).
PubMedID- 22675319 The expression of dlk1-dio3 mirna was examined in 97 patients with hepatocellular carcinoma (hcc) associated with hepatitis b infection.
PubMedID- 21809355 We aimed to investigate the incidence of occult hepatitis b infection (obi) in patients with "cryptogenic" hepatocellular carcinoma (hcc) and to study the hbv replicative activity in these patients.
PubMedID- 20924214 Background/aims: whether alcohol intake increases the risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection remains controversial.
PubMedID- 25873850 The present case was a young man, a known case of chronic hepatitis b with multiple recurrent hepatocellular carcinoma, who presented with clinical sepsis and jaundice.
PubMedID- 24614696 Background: risk factors can affect candidacy and prognosis following orthotopic liver transplantation (olt) with antiviral prophylaxis for the treatment of hepatocellular carcinoma (hcc) associated with hepatitis b virus (hbv) and cirrhosis.
PubMedID- 25735064 A 65-year-old woman had previously undergone ldlt for hepatocellular carcinoma associated with hepatitis b virus infection.
PubMedID- 23615731 A tissue microarray containing hepatocellular carcinoma samples with hepatitis b-positive patients (50 cases, 2 cores per case) and two non-neoplastic liver samples (2 cores per sample) was purchased from accumax (a217).
PubMedID- 23250907 Enhancers and attenuators of risk associations of chronic hepatitis b virus infection with hepatocellular carcinoma in type 2 diabetes.
PubMedID- 24570914 Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis b virus infection.
PubMedID- 25312649 The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis b on long-term nucleos(t)ide analogue therapy.
PubMedID- 23586065 Aim: to evaluate the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection.
PubMedID- 22271485 Statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection.
PubMedID- 24570913 Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 26350363 Background: hepatocellular carcinoma (hcc) not associated with active hepatitis b virus (hbv) or hepatitis c virus (hcv) infection, termed non-b non-c hcc (nbnc-hcc), is reportedly correlated with better survival outcomes than hbv- or hcv-related hcc.
PubMedID- 25478255 A 62-year-old woman, with cirrhosis due to hepatitis b associated with hepatocellular carcinoma, was submitted to living donor liver transplantation.
PubMedID- 24148650 Outcomes following liver resection and clinical pathologic characteristics of hepatocellular carcinoma occurring in patients with chronic hepatitis b and minimally fibrotic liver.
PubMedID- 24745029 We evaluated clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-b non-c (nbnc) hepatocellular carcinoma (hcc) patients with comparison to hepatitis b or c virus, paying attention to relationship between alcohol consumption and histopathological findings.
PubMedID- 22444598 Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis b infection.
PubMedID- 26421022 The objective of this study was to investigate risk factors for intrahepatic recurrence after resection of hepatocellular carcinoma, especially in patients with hepatitis b virus infection.
PubMedID- 24023999 A 49 year-old woman (160.0 cm, 94.6 kg) suffering from hepatocellular carcinoma with end-stage hepatitis b liver cirrhosis (model for end stage liver disease meld score 14, child-pugh class b) presented for living donor lt. she had hypertension that was well controlled with medications.
PubMedID- 21319289 Second neoplasms appeared in 3 patients, 1 of whom died of hepatocellular carcinoma following infection with hepatitis b.
PubMedID- 24995497 Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis b virus infection.
PubMedID- 24930484 Here, we assessed the prognostic performance of lsps in predicting the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb).
PubMedID- 24704525 Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis b: a nationwide cohort study.
PubMedID- 22819910 Background/aims: we investigated the clinicopathological findings and outcome after surgery for hepatocellular carcinoma in patients without hepatitis b or c virus infection.
PubMedID- 23044807 Association of xrcc1, xrcc3, and xpd genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis b and c virus.
PubMedID- 22972059 Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 22231575 Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis b virus infection.
PubMedID- 22436980 Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis b virus infection--results from a clinic-based longitudinal cohort.
PubMedID- 24976705 hepatitis b virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy.
PubMedID- 21104161 Association of novel mutations and haplotypes in the pres region of hepatitis b virus with hepatocellular carcinoma.
PubMedID- 24312130 To investigate whether killer cell immunoglobulin-like receptor (kir) and human leukocyte antigen (hla) genetic background could influence the onset age of hepatocellular carcinoma (hcc) in patients with hepatitis b virus (hbv) infection, one hundred and seventy-one males with hbv-related hcc were enrolled.
PubMedID- 23898389 Patients less than 18 years old; patients with neoplasm including hemangioma, liver cyst, and hepatocellular carcinoma; coinfection of hepatitis b and c; hepatitis b healthy carrier with normal transaminase; alcoholic liver disease (20 g/day or more for males, 10 g/day or more for females); autoimmune hepatitis; and metabolic liver diseases such as wilson's disease were other criteria of exclusion.
PubMedID- 23098862 Chronic infection with the hepatitis b virus can lead to hepatocellular carcinoma and cirrhosis in up to 25% of infected individuals.
PubMedID- 24387289 Background: chronic hepatitis b (chb) may lead to cirrhosis, hepatocellular carcinoma and premature death.
PubMedID- 24576055 Background & aims: the aim of this study was to re-evaluate the diagnostic performance of alpha-foetoprotein (afp) as a surveillance test for hepatocellular carcinoma (hcc) in patients with hepatitis b virus-related chronic liver disease who were treated with entecavir (etv).
PubMedID- 24485003 Thus, the present study was designed to investigate the protective effect of s-adenosylmethionine (same) on hiri, especially for patients with hepatocellular carcinoma (hcc) associated with chronic hepatitis b virus (hbv) infection and cirrhosis.
PubMedID- 22118340 The chb natural history influenced density of tumour-infiltrating tregs in hepatocellular carcinoma patients with chronic hepatitis b viruses infection.
PubMedID- 23236406 The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis b virus infection and cirrhosis.
PubMedID- 26133818 Correlation between polymorphisms in the human leukocyte antigen-dqb1 alleles and hepatitis b with primary hepatocellular carcinoma.
PubMedID- 24393929 A 61-year-old man who complained of right hypochondralgia was diagnosed as hepatocellular carcinoma (hcc) associated with hepatitis b virus (hbv) infection.
PubMedID- 24122900 Does long-term entecavir treatment really reduce hepatocellular carcinoma incidence in patients with hepatitis b virus infection.
PubMedID- 22372460 hepatocellular carcinoma (hcc) in a patient with hepatitis b virus (hbv) infection.
PubMedID- 21480326 Few studies have evaluated the risk of cancers other than hepatocellular carcinoma associated with hepatitis b virus (hbv) infection.
PubMedID- 23661457 Evaluation of a histocompatibility antigen related to hepatitis b virus in patients with hepatocellular carcinoma in the western brazilian amazon.

Page: 1 2 3